increas
incid
preval
asthma
mani
part
world
continu
make
global
health
concern
heterogen
natur
clinic
manifest
therapeut
respons
asthma
adult
pediatr
patient
indic
may
syndrom
rather
specif
diseas
entiti
numer
trigger
factor
includ
viral
infect
allergen
irrit
exposur
exercis
among
other
complic
acut
chronic
treatment
asthma
therapeut
intervent
focus
appreci
airway
obstruct
asthma
compos
bronchial
smooth
muscl
spasm
variabl
degre
airway
inflamm
character
edema
mucu
secret
influx
varieti
inflammatori
cell
presenc
partial
revers
airflow
obstruct
patient
indic
structur
remodel
airway
may
also
occur
time
choos
appropri
medic
depend
diseas
sever
intermitt
mild
persist
moder
persist
sever
persist
extent
revers
acut
chronic
pattern
diseas
activ
exacerb
relat
virus
allergen
exercis
etc
age
onset
infanc
childhood
adulthood
j
allergi
clin
immunol
despit
mark
heterogen
asthma
phenotyp
consensu
definit
asthma
develop
recogn
disord
chronic
inflammatori
disord
airway
mani
cell
cellular
element
play
role
particular
mast
cell
eosinophil
lymphocyt
neutrophil
epitheli
cell
suscept
individu
inflamm
caus
recurr
episod
wheez
breathless
chest
tight
cough
particularli
night
andor
earli
morn
episod
usual
associ
widespread
variabl
airflow
obstruct
often
revers
either
spontan
treatment
inflamm
also
caus
associ
increas
exist
bronchial
hyperrespons
varieti
stimuli
definit
number
key
point
regard
recognit
treatment
underli
caus
asthma
deserv
highlight
asthma
whatev
sever
chronic
inflammatori
disord
airway
characterist
implic
diagnosi
prevent
treatment
diseas
airway
inflamm
may
variabl
associ
chang
airway
hyperrespons
airflow
limit
respiratori
symptom
diseas
chronic
airway
inflamm
may
acut
chronic
associ
develop
airflow
limit
result
bronchoconstrict
airway
edema
mucu
secret
patient
airway
wall
remodel
airway
inflamm
histopatholog
featur
found
adult
asthmat
patient
may
begin
earli
childhood
highrisk
individu
atopi
genet
predisposit
develop
antigenspecif
igemedi
respons
common
aeroallergen
strongest
identifi
predispos
factor
develop
asthma
genet
asthma
recent
extens
review
present
investig
would
agre
major
hereditari
contribut
underli
caus
asthma
allerg
diseas
howev
inherit
pattern
asthma
demonstr
complex
genet
disord
seen
hypertens
atherosclerosi
arthriti
diabet
mellitu
asthma
classifi
simpli
autosom
domin
recess
sexlink
mode
inherit
studi
evalu
diseasecaus
diseasemodifi
gene
demonstr
linkag
follow
chromosom
chromosom
region
total
ige
eosinophil
level
cytokin
interleukin
endotoxin
receptor
import
initi
innat
immun
respons
major
histocompat
complex
tumor
necrosi
factor
complex
asthma
inflamm
highaffin
ige
receptor
asthma
atopi
asthma
among
other
recent
gene
encod
proteinprocess
enzym
known
metalloproteas
found
commonli
associ
asthma
addit
determin
extent
polymorph
variat
treatment
respons
gene
term
pharmacogenet
come
forefront
asthma
research
thu
far
primari
focu
research
activ
direct
toward
character
gene
relat
respons
pathway
glucocorticoid
receptor
feasibl
asthma
treatment
program
futur
may
individu
base
natur
patient
polymorph
variat
gene
found
significantli
influenc
therapeut
respons
acut
chronic
clinic
symptom
result
pathophysiolog
asthma
direct
extens
airway
obstruct
appreci
airway
obstruct
effect
lung
physiolog
patient
symptom
number
factor
need
consid
first
airway
obstruct
intermitt
persist
andor
progress
second
airway
obstruct
total
partial
revers
third
airflow
obstruct
end
result
multipl
structur
andor
physiolog
factor
individu
collect
contribut
airway
narrow
final
precis
contribut
featur
vari
among
asthmat
patient
contribut
divers
clinic
manifest
includ
sever
diseas
therapeut
respons
variou
medic
airway
smooth
muscl
spasm
one
characterist
featur
asthma
airway
hyperrespons
mean
acut
airflow
obstruct
occur
sever
stimuli
result
contractil
respons
lead
excess
airway
narrow
bronchial
smooth
muscl
spasm
probabl
instrument
excess
reactiv
mani
factor
airway
regul
contribut
airway
smooth
muscl
tone
exampl
airway
contain
number
resid
cell
mast
cell
alveolar
macrophag
airway
epithelium
endothelium
well
immigr
inflammatori
cell
eosinophil
lymphocyt
neutrophil
basophil
possibl
platelet
cell
capabl
secret
varieti
mediat
histamin
cysteinyl
leukotrien
ltc
ltd
lte
prostaglandin
plateletactiv
factor
directli
contract
bronchial
smooth
muscl
addit
recruit
cell
gener
inflammatori
mediat
caus
airway
smooth
muscl
becom
contract
bronchospasm
mediat
airway
smooth
muscl
also
neuroregulatori
control
innerv
vagu
nerv
either
direct
activ
nerv
reflex
mechan
secret
acetylcholin
lead
bronchial
muscl
contract
furthermor
neuroregul
mediat
substanc
p
neurokinin
determin
airway
smooth
muscl
tone
airway
mucos
edema
mani
mediat
lead
bronchial
smooth
muscl
contract
exampl
histamin
cysteinyl
leukotrien
bradykinin
increas
capillari
membran
permeabl
caus
mucos
edema
chang
airway
tissu
also
lead
airway
flow
obstruct
mucu
hypersecret
one
characterist
featur
sever
asthma
overproduct
mucu
mucu
mechan
narrow
airway
lumen
sever
asthma
form
tenaci
plug
obliter
airway
develop
mucou
plug
airway
occur
either
sever
prolong
attack
asthma
patient
chronic
diseas
end
result
compromis
airway
lumen
inflamm
airway
inflamm
characterist
featur
asthma
contribut
significantli
mani
featur
diseas
includ
airflow
obstruct
bronchial
hyperrespons
initi
injuryrepair
process
remodel
found
patient
pattern
inflamm
vari
consider
depend
stage
diseas
acut
chronic
remodel
see
degre
airway
inflamm
vari
sever
chronic
diseas
may
also
determin
respons
patient
treatment
tissu
patient
die
statu
asthma
show
characterist
pattern
airway
inflamm
includ
denud
airway
epithelium
mucou
plug
segment
bronchi
bronchiol
collagen
deposit
beneath
basement
membran
edema
submucosa
infiltr
inflammatori
cell
neutrophil
seen
frequent
exacerb
sudden
sever
eosinophil
smooth
muscl
hypertrophyhyperplasia
gradat
respons
seen
diseas
sever
move
mild
asthma
chronic
persist
process
mani
inflammatori
cell
contribut
airway
inflamm
asthma
includ
activ
mast
cell
lymphocyt
particularli
h
subpopul
cell
releas
famili
proinflammatori
cytokin
includ
cytokin
assist
recruit
activ
eosinophil
lymphocyt
along
epitheli
cell
gener
chemokin
includ
rant
eotaxin
appear
essenti
recruit
eosinophil
anoth
critic
step
process
activ
endotheli
adhes
protein
particularli
immunoglobulin
superfamili
protein
combin
specif
receptor
inflammatori
cell
exampl
neutrophil
eosinophil
lymphocyt
reduc
flow
vessel
assist
cell
movement
airway
fig
remodel
recent
evid
demonstr
patient
asthma
irrevers
airflow
obstruct
process
term
airway
remodel
repres
injuryrepair
process
airway
tissu
number
compon
airway
remodel
asthma
identifi
includ
airway
smooth
muscl
hypertrophi
mucu
gland
goblet
cell
hyperplasia
angiogenesi
vascular
hyperplasia
collagen
deposit
airway
histolog
featur
appear
perman
revers
treatment
although
consequ
airway
remodel
appreci
process
involv
regul
yet
fulli
defin
nonetheless
process
appear
control
mediat
quit
distinct
involv
acut
inflammatori
respons
exampl
remodel
gener
presenc
growth
factor
appear
critic
lead
structur
chang
airway
tissu
thu
shift
transit
remodel
allerg
inflamm
suggest
new
famili
mediat
action
smooth
muscl
growth
collagen
deposit
blood
vessel
prolifer
mucou
gland
hyperplasia
collect
new
data
provid
pictur
asthma
begin
acut
cellular
inflammatori
respons
may
evolv
chronic
process
structur
chang
occur
airway
affect
airway
hyperrespons
airflow
obstruct
one
characterist
featur
asthma
airway
hyperrespons
varieti
inhal
substanc
eg
methacholin
associ
exposur
cold
air
exercis
irrit
hyperventil
mani
factor
contribut
hyperrespons
seen
asthma
includ
genet
polymorph
airway
architectur
ie
edema
smooth
muscl
hypertrophi
deposit
collagen
materi
age
time
day
nighttim
versu
daytim
airway
hyperrespons
demonstr
infanc
earli
childhood
may
risk
factor
subsequ
develop
clinic
asthma
although
airway
inflamm
contribut
physiolog
aberr
asthma
multipl
factor
influenc
airway
calib
play
role
well
import
emphas
airway
hyperrespons
uniqu
asthma
posit
methacholin
challeng
test
diagnost
airway
hyperrespons
seen
atop
patient
cystic
fibrosi
chronic
lung
diseas
even
normal
individu
week
viral
respiratori
tract
infect
asthma
per
se
potenti
use
test
neg
eg
evalu
chronic
cough
sinc
unusu
patient
clinic
asthma
level
airway
respons
would
fall
normal
rang
asthma
classifi
basi
etiolog
factor
sever
pattern
airflow
limit
sinc
asthma
heterogen
disord
multipl
caus
factor
doubt
exist
incept
symptom
exacerb
diseas
establish
factor
underli
incept
rang
viral
respiratori
tract
infect
infanc
eg
respiratori
syncyti
viru
occup
exposur
adult
factor
underli
asthma
exacerb
includ
allergen
exposur
sensit
individu
viral
infect
exercis
irrit
ingest
nonsteroid
antiinflammatori
agent
among
other
exacerb
factor
may
includ
one
exposur
vari
among
within
patient
convent
assess
asthma
sever
combin
evalu
symptom
amount
agonist
use
treat
symptom
lung
function
base
type
assess
sever
patient
asthma
treatment
classifi
expert
panel
intermitt
three
level
persist
diseas
mild
moder
sever
fig
patient
alreadi
receiv
treatment
classif
sever
base
clinic
featur
present
step
daili
medic
patient
current
receiv
thu
patient
ongo
symptom
moder
persist
asthma
despit
receiv
appropri
mainten
treatment
step
fig
regard
moder
persist
asthma
emphas
classif
scheme
pertain
diseas
sever
chronic
patient
intermitt
symptom
eg
viralinduc
asthma
young
children
still
sever
deterior
lung
function
acut
exacerb
importantli
individu
low
incom
medic
underserv
innerc
popul
certain
cultur
group
increas
risk
sever
asthma
allergen
allergen
exposur
import
host
allerg
sensit
common
precipit
asthmat
symptom
children
adult
develop
allerg
diseas
involv
first
process
sensit
allergenspecif
ige
antibodi
format
genet
predispos
atop
individu
second
express
target
respons
variou
organ
system
eg
nose
skin
lung
forth
asthma
target
organ
obvious
lung
immunoinflammatori
event
upper
airway
may
contribut
loss
asthma
control
well
format
antigenspecif
ige
antibodi
aeroallergen
eg
mite
tree
grass
anim
dander
usual
occur
year
life
thu
aeroallergeninduc
asthma
uncommon
first
year
life
begin
increas
preval
later
childhood
adolesc
peak
second
decad
life
establish
genet
predispos
individu
igemedi
reaction
major
contributor
acut
asthmat
symptom
chronic
airway
inflamm
chronic
lowlevel
exposur
indoor
allergen
dust
mite
cockroach
particular
may
play
major
role
asthma
pathogenesi
subsequ
provoc
symptom
although
wide
varieti
inhal
allergen
provok
asthma
symptom
sensit
hous
dust
mite
cockroach
alternaria
possibl
cat
import
pathogenesi
asthma
paradox
recent
data
would
suggest
exposur
cat
dog
earli
life
may
actual
protect
develop
asthma
featur
allergen
develop
asthma
fulli
establish
may
relat
enzymat
well
antigen
activ
alternaria
exposur
particular
may
produc
sever
acut
asthmat
symptom
sensit
alternaria
implic
risk
factor
sudden
respiratori
arrest
adolesc
young
adult
asthma
although
food
allergi
may
produc
bronchospasm
along
skin
andor
gastrointestin
symptom
unusu
food
allergi
produc
isol
respiratori
reaction
infect
respiratori
tract
infect
caus
virus
chlamydia
mycoplasma
implic
pathogenesi
asthma
respiratori
pathogen
virus
demonstr
associ
asthma
least
three
way
first
infanc
certain
virus
implic
potenti
respons
incept
asthmat
phenotyp
viru
convincingli
demonstr
regard
respiratori
syncyti
viru
rsv
howev
sinc
nearli
everi
child
infect
least
viru
year
age
addit
genet
environment
development
factor
must
contribut
propens
particular
viru
link
childhood
asthma
second
patient
establish
asthma
particularli
children
viral
upper
respiratori
tract
infect
play
signific
role
produc
acut
exacerb
airway
obstruct
may
result
frequent
outpati
visit
hospit
rhinoviru
common
cold
viru
frequent
caus
exacerb
virus
includ
parainfluenza
rsv
influenza
coronaviru
also
implic
albeit
lesser
extent
increas
tendenc
viral
infect
produc
lower
airway
symptom
asthmat
individu
may
relat
least
part
interact
among
allerg
sensit
allergen
exposur
viral
infect
act
cofactor
induct
acut
episod
airflow
obstruct
third
paradox
infect
consid
potenti
actual
prevent
develop
allerg
respiratori
tract
diseas
includ
asthma
interest
area
increas
advanc
hygien
hypothesi
propos
increas
famili
size
coincid
increas
number
infect
may
protect
develop
basi
progress
broader
interpret
initi
hypothesi
number
epidemiolog
biolog
factor
evalu
regard
abil
influenc
develop
allerg
sensit
andor
asthma
stepwis
approach
treat
infant
young
children
year
age
younger
acut
chronic
asthma
reproduc
http
wwwnhlbinihgovguidelinesasthmaasthsummhtm
infect
microbi
agent
recent
attent
focus
chlamydia
mycoplasma
potenti
contributor
exacerb
sever
chronic
asthma
term
loss
lung
function
medic
requir
final
infect
involv
upper
airway
ie
sinus
consid
contribut
asthma
control
instabl
evok
concept
unifi
airway
relat
inflammatori
respons
alter
airway
physiolog
stepwis
approach
treat
asthma
adult
children
older
year
age
reproduc
http
wwwnhlbinihgovguidelinesasthmaasthsummhtm
treatment
infectionassoci
asthma
depend
microb
involv
age
patient
virusinduc
asthma
exacerb
oral
corticosteroid
effect
form
therapi
diseas
sever
chronic
relat
either
chlamydia
mycoplasma
treatment
macrolid
antibiot
may
consid
exercis
exercis
one
common
precipit
airway
obstruct
asthmat
patient
symptom
exerciseinduc
bronchospasm
eib
may
includ
follow
wheez
cough
short
breath
children
chest
pain
discomfort
symptom
intens
minut
usual
resolv
within
minut
exercis
cessat
given
suffici
exercis
stimulu
maxim
heart
rate
minut
clinic
pattern
eib
fairli
characterist
bronchodil
initi
respons
exercis
occur
normal
individu
subject
asthma
may
mediat
releas
catecholamin
respons
transient
peak
midexercis
return
baselin
end
exercis
progress
bronchospasm
ensu
maxim
obstruct
occur
minut
cessat
exercis
spontan
remiss
usual
follow
pulmonari
function
return
baselin
within
minut
circumst
degre
bronchoconstrict
rare
sever
enough
lifethreaten
situat
almost
invari
reflect
advanc
untreat
diseas
confound
trigger
factor
ie
concomit
allergen
irrit
exposur
eib
apt
occur
short
minut
period
intens
exercis
although
obstruct
shown
occur
exercis
durat
minut
individu
eib
capabl
run
symptom
despit
continu
exercis
presenc
acut
asthma
gradual
spontan
resolut
bronchospasm
occur
give
subject
second
wind
make
diagnosi
eib
object
document
airflow
obstruct
exercis
challeng
test
convinc
histori
appropri
respons
prophylact
rescu
medic
requir
exercis
challeng
test
must
suffici
intens
durat
abl
accur
diagnos
condit
keep
mind
confound
problem
vocal
cord
dysfunct
may
need
consid
differenti
diagnosi
classic
appropri
exercis
stimulu
decreas
peak
flow
fev
highli
suspici
decreas
diagnost
eib
nonsteroid
antiinflammatori
drug
approxim
asthmat
patient
acut
worsen
symptom
nonsteroid
antiinflammatori
drug
nsaid
aspirin
triad
asthma
nasal
polyp
aspirin
sensit
usual
found
adult
asthmat
patient
respons
aspirin
nsaid
begin
within
hour
aspirin
ingest
associ
profound
rhinorrhea
eye
lacrim
potenti
sever
bronchospasm
patient
sensit
aspirin
usual
reactiv
nsaid
variat
frequenc
sever
advers
respons
appear
depend
potenc
drug
within
class
compound
inhibit
activ
cyclooxygenas
cox
enzym
use
inhibitor
aspirinsensit
patient
usual
problem
major
patient
rofecoxib
recent
shown
excel
safeti
profil
regard
sensit
nsaid
igemedi
involv
modul
eicosanoid
product
suggest
nsaid
act
reduc
format
prostaglandin
help
maintain
normal
airway
function
increas
format
asthmaprovok
eicosanoid
includ
hydroxyeicosatetraeno
acid
larg
quantiti
cysteinyl
leukotrien
addit
evid
mast
cell
activ
occur
mediat
detect
nasal
secret
episod
aspirininduc
asthma
precis
phenotyp
patient
risk
aspirininduc
respons
yet
fulli
describ
overexpress
leukotrien
c
synthas
associ
syndrom
howev
syndrom
concern
asthmat
patient
nasal
polyposi
chronic
sinus
eosinophilia
although
polyposi
sinus
may
preced
onset
recogn
nsaid
sensit
year
gastroesophag
reflux
true
incid
gastroesophag
reflux
diseas
gerd
asthma
caus
factor
diseas
sever
yet
establish
howev
estim
mani
adult
children
asthma
gerd
mechan
gerd
affect
asthma
also
establish
may
includ
microaspir
irrit
esophagu
reflex
bronchospasm
although
often
asymptomat
present
mani
patient
nighttim
exacerb
difficulttocontrol
symptom
confirm
import
gerd
asthma
often
requir
endoscopi
monitor
intraesophag
ph
level
concomit
measur
peak
expiratori
flow
rate
recognit
factor
asthma
sever
import
sinc
effect
therapi
current
avail
psychosoci
factor
role
psychosoci
factor
stress
undergon
import
reevalu
term
diseas
risk
factor
concomit
compon
sever
addit
patient
stress
act
autocrin
fashion
recent
evid
shown
parent
stress
risk
factor
asthma
express
children
mechan
occur
defin
may
includ
promot
allerg
inflamm
asthma
obstruct
lung
diseas
defin
decreas
fev
fvc
ratio
differ
obstruct
lung
diseas
emphysema
cystic
fibrosi
forth
diffus
capac
normal
airway
obstruct
usual
revers
partial
complet
measur
pulmonari
function
essenti
assess
sever
asthma
also
use
monitor
cours
asthma
patient
respons
therapi
spirometri
recommend
initi
assess
patient
suspect
asthma
subsequ
measur
peak
expiratori
flow
pef
home
may
help
guid
assess
symptom
alert
worsen
airflow
obstruct
monitor
therapeut
respons
abnorm
pulmonari
function
measur
reflect
degre
airflow
obstruct
reflect
consequ
asthma
airway
mechan
typic
spirometr
abnorm
exacerb
symptom
includ
reduct
fev
pef
fev
forc
vital
capac
ratio
increas
fev
respons
bronchodil
howev
failur
demonstr
improv
bronchodil
interpret
absolut
evid
irrevers
diseas
airway
rather
major
compon
obstruct
inflamm
bronchospasm
demonstr
extent
revers
often
requir
administr
corticosteroid
abnorm
lung
volum
includ
decreas
vital
capac
increas
function
residu
capac
total
lung
capac
residu
volum
predict
normal
valu
acut
attack
addit
abnorm
paramet
pulmonari
function
includ
decreas
frequencydepend
complianc
sensit
indic
obstruct
small
airway
increas
airway
resist
decreas
reciproc
specif
airway
conduct
simpl
pulmonari
function
test
pef
fev
perform
routin
outpati
set
use
method
monitor
cours
asthma
help
manag
asthma
home
system
pef
zone
use
correl
pef
measur
variabl
appropri
level
medic
control
asthma
action
plan
target
symptom
control
versu
pef
valu
also
util
superior
lack
thereof
approach
achiev
maintain
asthma
control
recent
evalu
http
wwwnhlbinihgovguidelinesasthmaasthsumm
htm
consensu
opinion
current
evid
neither
support
refut
benefit
written
action
plan
base
pef
monitor
compar
symptombas
plan
improv
health
care
util
symptom
lung
function
patient
moder
sever
persist
asthma
home
peak
flow
monitor
consid
may
enhanc
clinicianpati
commun
may
increas
patient
care
giver
awar
diseas
statu
control
methacholin
airway
hyperrespons
physiolog
characterist
asthma
presenc
help
establish
diagnosi
although
hyperrespons
diagnost
asthma
absenc
strong
indic
condit
evalu
unlik
asthma
airway
hyperrespons
identifi
quantifi
pulmonari
test
facil
use
bronchial
challeng
provoc
techniqu
help
establish
presenc
asthma
baselin
lung
function
normal
diagnosi
question
commonli
employ
method
use
evalu
airway
hyperrespons
includ
inhal
provoc
methacholin
direct
stimuli
exercis
challeng
indirect
stimuli
direct
stimuli
act
upon
relev
receptor
bronchial
smooth
muscl
stimul
airway
muscl
contract
directli
indirect
stimuli
result
airway
smooth
muscl
contract
one
intermedi
mechan
includ
local
central
neuron
reflex
activ
resid
eg
mast
cell
nonigedepend
mediat
releas
inflammatori
cell
other
bronchoprovoc
studi
methacholin
sensit
less
specif
exercis
challeng
diagnos
asthma
addit
indirect
airway
respons
correl
better
asthma
sever
asthma
symptom
airway
inflamm
perform
methacholin
bronchoprovoc
chang
pulmonari
function
ie
fall
fev
measur
serial
spirometri
patient
inhal
increment
dose
methacholin
peopl
asthma
respond
bronchoprovoc
greater
degre
airflow
obstruct
normal
subject
concentr
patient
respond
provoc
concentr
caus
fall
fev
pc
defin
level
bronchial
respons
bronchial
provoc
help
differenti
diagnosi
asthma
histori
physic
find
baselin
lung
function
adequ
confirm
clinic
diagnosi
asthma
cough
variant
asthma
evalu
exerciseinduc
dyspnea
exercis
establish
diagnosi
eib
exercis
challeng
perform
exercis
loss
airway
heat
water
provok
bronchospasm
simul
condit
laboratori
patient
exercis
minut
achiev
patient
maximum
predict
oxygen
consumpt
formal
laboratori
set
exercis
challeng
often
done
treadmil
exercis
rais
patient
heart
rate
produc
oxygen
util
minut
pulmonari
function
measur
fev
determin
exercis
interv
minut
altern
patient
run
outdoor
perform
amount
type
exercis
associ
symptom
minut
brisk
pace
pef
monitor
challeng
type
challeng
help
recreat
condit
associ
induct
respiratori
symptom
exercis
physiologist
would
consid
decreas
consist
decreas
diagnost
exerciseinduc
bronchospasm
chest
radiographi
patient
newli
diagnos
asthma
chest
radiograph
often
obtain
rule
coexist
diseas
howev
abnorm
relat
asthma
unusu
acut
exacerb
commonli
hyperinfl
mucou
plug
result
atelectasi
occasion
sever
asthma
pneumothorax
pneumomediastinum
may
occur
chest
radiograph
situat
provid
help
inform
signific
compromis
lung
space
assist
ventil
requir
benefit
newer
techniqu
highresolut
computer
axial
tomographi
diagnosi
treatment
asthma
fulli
assess
peripher
white
blood
cell
count
although
peripher
white
blood
cell
count
add
littl
overal
asthma
treatment
find
peripher
blood
eosinophilia
either
assist
diagnosi
asthma
provid
surrog
marker
asthma
sever
children
increas
absolut
eosinophil
count
may
predictor
futur
asthma
risk
arteri
blood
gase
arteri
blood
ga
measur
reflect
consequ
airflow
obstruct
arteri
oxygen
level
carbon
dioxid
develop
airflow
obstruct
asthma
uneven
distribut
inspir
air
reflect
ventilationperfus
ratio
mild
moder
exacerb
asthma
hypoxia
develop
becom
sever
airflow
obstruct
intensifi
blood
ga
analys
obtain
patient
acut
exacerb
asthma
sever
impair
pulmonari
function
test
failur
respond
therapi
period
histori
frequent
hospit
asthma
multipl
emerg
depart
visit
preced
hour
day
earliest
abnorm
arteri
blood
ga
level
respiratori
alkalosi
hypocarbia
partial
pressur
oxygen
remain
normal
increas
sever
asthma
hypoxia
intens
alter
carbon
dioxid
ph
evalu
close
appear
normal
pco
suggest
patient
fatigu
wherea
acidemia
increas
pco
indic
impend
respiratori
failur
therefor
patient
sever
exacerb
progress
stage
hypoxemia
respiratori
alkalosi
hypoxemia
normal
ph
pco
stage
impend
respiratori
failur
recogn
possibl
progress
essenti
treat
clinician
get
fals
sens
secur
blood
ga
find
consist
moder
exacerb
present
infant
children
wheez
symptom
princip
associ
asthma
common
clinic
present
infanc
childhood
approxim
children
least
one
wheez
ill
year
age
nearli
year
age
almost
year
age
major
episod
trigger
viral
respiratori
tract
infect
howev
multipl
caus
wheez
age
group
also
must
consid
includ
cystic
fibrosi
anatom
abnorm
eg
vascular
ring
tracheomalacia
bronchomalacia
foreign
bodi
aspir
gastroesophag
reflux
among
other
nonasthmat
wheez
ill
exclud
character
variou
wheez
phenotyp
subsequ
risk
later
develop
asthma
determin
age
year
base
time
onset
pattern
wheez
symptom
children
group
least
three
wheez
phenotyp
transient
wheezer
present
first
year
gone
age
year
persist
wheezer
present
first
year
still
present
beyond
age
year
lateonset
wheezer
present
first
year
symptom
begin
year
age
transient
wheez
associ
diminish
lung
function
possibl
relat
reduc
lung
size
birth
time
tend
normal
lateonset
wheez
associ
increas
tendenc
toward
allerg
sensit
rel
stabl
lung
function
least
first
decad
life
persist
wheez
commonli
seen
children
asthmat
parent
signific
lower
respiratori
tract
ill
respiratori
syncyti
viru
southwestern
part
unit
state
allerg
sensit
mold
alternaria
importantli
children
persist
wheez
tend
near
normal
level
lung
function
birth
decreas
significantli
first
year
life
thu
prevent
attenu
loss
lung
function
possibl
earli
recognit
treatment
children
persist
wheez
appear
critic
assist
clinician
identifi
children
high
risk
develop
asthma
asthma
risk
index
recent
develop
basi
result
obtain
larg
cohort
children
follow
birth
adolesc
children
histori
recurr
wheez
episod
past
year
one
physiciandiagnos
either
one
major
criteria
parent
histori
asthma
physiciandiagnos
atop
dermat
aeroallergen
sensit
two
minor
criteria
peripher
eosinophilia
food
sensit
wheez
unrel
infect
chanc
asthma
age
year
none
criteria
present
chanc
child
asthma
age
current
clinic
trial
perform
determin
children
posit
asthma
risk
index
identifi
treat
earli
childhood
incid
develop
asthma
reduc
andor
decreas
lung
function
prevent
adult
like
children
cardin
clinic
featur
asthma
includ
cough
wheez
short
breath
nonspecif
symptom
respiratori
problem
need
consid
diagnosi
asthma
furthermor
asthma
may
intermitt
sever
abnorm
physic
examin
lung
function
may
absent
time
evalu
therefor
diagnosi
asthma
requir
recognit
import
histor
item
physic
examin
also
evalu
presenc
coexist
ill
use
pulmonari
function
alter
revers
airflow
obstruct
presenc
bronchial
hyperrespons
mani
factor
caus
wheez
children
masquerad
asthma
found
adult
includ
upper
airway
obstruct
foreign
bodi
tracheal
compress
lumin
extralumin
tracheal
diseas
frequent
confound
problem
vocal
cord
dysfunct
vcd
patient
vcd
acut
respiratori
distress
loud
audibl
wheez
measur
airflow
obstruct
pulmonari
function
test
patient
clinic
pictur
complic
vcd
asthma
coexist
two
common
caus
chronic
obstruct
lung
diseas
adult
emphysema
chronic
bronchiti
differenti
asthma
basi
abnorm
diffus
capac
emphysema
cough
sputum
product
chronic
bronchiti
smoke
histori
note
asthma
may
coexist
condit
make
find
revers
challeng
interpret
case
eosinophilia
characterist
featur
asthma
number
pulmonari
diseas
wheez
pulmonari
infiltr
eosinophilia
includ
allerg
bronchopulmonari
aspergillosi
chronic
eosinophil
pneumonia
churgstrauss
syndrom
presenc
recurr
persist
infiltr
chest
radiographi
indic
patient
uncompl
asthma
medic
adrenerg
agonist
adrenerg
drug
potent
rapidli
act
bronchodil
clinic
use
today
avail
multipl
form
short
intermedi
longact
deliveri
system
metereddos
inhal
mdi
nebul
solut
oral
liquid
tablet
respir
powder
give
wide
clinic
versatil
see
fig
addit
relax
airway
smooth
muscl
agonist
enhanc
mucociliari
clearanc
decreas
vascular
permeabl
may
modul
mediat
releas
mast
cell
side
effect
select
agonist
includ
tremor
tachycardia
increas
anxieti
effect
minim
administ
inhal
acut
rescu
treatment
asthma
exacerb
intermediateact
albuterol
terbutalin
pirbuterol
agonist
may
use
everi
hour
aerosol
deliveri
devic
mdi
nebul
need
frequent
administr
twice
weekli
symptom
relief
ie
rescu
use
alert
treat
physician
patient
underli
diseas
process
ie
inflamm
need
aggress
appropri
intervent
fig
longact
salmeterol
formoterol
also
effect
treatment
moder
sever
persist
asthma
longact
use
monotherapi
patient
requir
daili
control
medic
howev
patient
receiv
inhal
corticosteroid
ic
whose
asthma
suboptim
control
agent
produc
better
overal
asthma
control
ad
baselin
dose
ic
achiev
doubl
dose
ic
one
outcom
measur
seem
differ
regard
frequenc
asthma
exacerb
increas
dose
ic
andor
ad
longact
baselin
dose
ic
provid
signific
improv
asthma
control
optim
introduct
longact
clinic
set
reduct
dose
elimin
ic
safe
institut
major
patient
interest
develop
levalbuterol
r
enantiom
racem
rs
albuterol
aros
data
anim
model
suggest
enantiom
may
produc
advers
effect
despit
approv
use
year
age
rel
advantag
use
levalbuterol
place
racem
albuterol
term
efficaci
safeti
question
number
investig
base
conflict
opinion
consensu
recommend
regard
use
substitut
racem
albuterol
possibl
studi
address
controversi
issu
theophyllin
theophyllin
methylxanthin
bronchodil
medic
may
mild
antiinflammatori
effect
well
sustainedreleas
theophyllin
prepar
aminophyllin
use
control
medic
asthma
children
adult
due
low
cost
use
mani
countri
treat
mild
diseas
although
use
addon
therapi
low
high
dose
inhal
glucocorticoid
asthma
control
need
less
effect
capac
addit
long
act
agonist
serum
level
theophyllin
due
liver
metabol
may
markedli
affect
number
variabl
includ
age
diet
diseas
state
drug
interact
contribut
complex
use
medic
addit
theophyllin
may
produc
number
doserel
side
effect
gastrointestin
symptom
may
intoler
patient
even
well
within
usual
therapeut
drug
level
children
take
theophyllin
concern
parent
teacher
suggest
theophyllin
might
advers
affect
school
perform
although
mani
studi
abl
substanti
associ
nonetheless
avoid
prescrib
theophyllin
children
preexist
behavior
andor
school
difficulti
seem
reason
cromolyn
nedocromil
cromolyn
sodium
nedocromil
sodium
two
structur
differ
antiinflammatori
medic
treatment
chronic
asthma
similar
properti
rapidli
absorb
lung
impress
safe
medic
bronchodil
shown
inhibit
inflammatori
cell
activ
mediat
releas
earli
late
allergeninduc
bronchoconstrict
reduc
airway
hyperrespons
mechan
action
agent
may
relat
effect
airway
epitheli
chlorid
channel
effect
local
neuron
reflex
cromolyn
shown
effect
adult
pediatr
patient
modestli
effect
prophylact
attenu
exerciseinduc
bronchospasm
albeit
less
agonist
agent
may
use
prophylaxi
relev
allergen
exposur
sensit
patient
longterm
treatment
persist
asthma
children
treatment
ic
shown
superior
nedocromil
achiev
overal
asthma
control
leukotrien
antagonist
leukotrien
biolog
activ
fatti
acid
deriv
oxid
metabol
arachidon
acid
integr
part
cell
membran
cysteinyl
leukotrien
ltc
ltd
lte
gener
eosinophil
mast
cell
alveolar
macrophag
combin
specif
receptor
cyslt
cyslt
major
action
cysteinyl
leukotrien
gener
interact
cyslt
receptor
lead
airway
smooth
muscl
contract
leukocyt
chemotaxi
increas
vascular
permeabl
action
leukotrien
prevent
inhibit
cysteinyl
leukotrien
synthesi
inhibitor
zileuton
antagonist
leukotrien
receptor
zafirlukast
montelukast
compound
receptor
antagonist
frequent
use
asthma
treatment
receptor
antagonist
shown
inhibit
exerciseprovok
bronchospasm
modifi
airway
respons
inhal
antigen
improv
airway
function
patient
chronic
asthma
adult
patient
asthma
leukotrien
receptor
antagonist
improv
airflow
obstruct
reduc
need
reduc
asthma
exacerb
headtohead
trial
inhal
corticosteroid
leukotrien
receptor
antagonist
less
effect
term
improv
lung
function
reduct
exacerb
howev
ad
baselin
dose
inhal
corticosteroid
class
compound
potenti
improv
overal
asthma
control
conveni
onceperday
oral
dose
montelukast
safeti
appeal
patient
increas
experi
clinic
respons
profil
pharmacogenet
variabl
precis
recommend
prescrib
prioriti
placement
possibl
glucocorticoid
glucocorticosteroid
potent
antiinflammatori
agent
avail
treatment
asthma
efficaci
relat
mani
factor
includ
diminut
inflammatori
cell
function
activ
stabil
vascular
leakag
decreas
mucu
product
increas
respons
glucocorticoid
produc
effect
variou
cell
bind
intracellular
glucocorticoid
receptor
gr
go
regul
transcript
certain
target
gene
steroidbound
gr
form
dimer
bind
dna
glucocorticoid
respons
element
gre
result
increas
transcript
increas
mrna
increas
synthesi
protein
howev
asthma
like
control
inflamm
come
repress
gene
transcript
ic
potenti
produc
system
side
effect
depend
dose
potenc
corticosteroid
well
bioavail
absorpt
gut
firstpass
metabol
liver
halflif
system
absorb
lung
possibl
gut
fraction
although
ic
use
recommend
dose
minim
advers
effect
except
oral
candidiasi
oral
hygien
suboptim
concern
rais
use
agent
children
may
associ
growth
suppress
howev
recent
data
reassur
two
longterm
studi
demonstr
although
reduct
growth
veloc
occur
cmi
within
first
month
therapi
use
recommend
dose
longterm
treatment
influenc
attain
predict
adult
height
major
children
howev
sinc
use
lowdos
ic
may
rare
advers
affect
growth
use
high
dose
ic
associ
signific
longterm
consequ
dose
reduct
attempt
whenev
possibl
use
variou
form
adjunct
control
medic
goal
use
corticosteroid
treatment
asthma
similar
use
class
medic
view
simplist
two
way
first
gain
control
underli
diseas
process
achiev
state
diseas
remiss
eg
statu
asthmaticu
patient
chronic
stabl
asthma
signific
diminut
lung
function
prolong
time
period
second
maintain
control
remiss
long
possibl
least
amount
side
effect
initi
action
usual
requir
highdos
ic
frequent
system
corticosteroid
remitt
therapi
usual
requir
oral
corticosteroid
burst
eg
mgkg
per
day
prednison
day
usual
adult
maximum
mgd
durat
burst
vari
consider
among
patient
goal
maxim
lung
function
minim
symptom
reduc
use
rescu
medic
time
ic
medic
start
dose
suffici
maintain
initi
remiss
prolong
period
time
dose
type
medic
may
influenc
age
deliveri
system
side
effect
cost
familiar
clinician
nuanc
variou
avail
product
emphas
abrupt
discontinu
ic
import
caus
asthma
exacerb
exacerb
asthma
asthma
attack
occur
varieti
reason
viral
respiratori
infect
allergen
exposur
aspirin
ingest
withdraw
medic
particularli
inhal
corticosteroid
treatment
exacerb
depend
age
patient
sever
episod
time
evalu
fig
mild
exacerb
may
treat
home
fig
cliniciangener
symptombas
action
plan
acut
sever
exacerb
asthma
potenti
lifethreaten
requir
critic
assess
appropri
therapi
determin
sever
asthma
exacerb
number
factor
evalu
histori
examin
assess
lung
function
fig
patient
exacerb
significantli
sever
requir
outpati
evalu
fig
brief
histori
physic
examin
necessari
appropri
begin
treatment
histor
import
sever
symptom
current
medic
includ
recent
corticosteroid
use
onset
symptom
prior
hospit
emerg
depart
visit
addit
physic
examin
determin
vital
sign
auscult
chest
breath
soundswheez
silent
chest
care
attent
direct
toward
alert
cyanosi
use
accessori
muscl
respir
retract
abdomin
breath
children
collect
featur
provid
object
insight
level
asthma
sever
assess
lung
function
use
peak
flow
meter
spirometri
fev
fvc
essenti
precis
determin
baselin
level
airflow
obstruct
ultim
respons
therapi
sever
airflow
obstruct
fev
histori
sever
respiratori
compromis
arteri
blood
ga
valu
assess
oxygen
carbon
dioxid
concentr
indic
impend
respiratori
failur
initi
treatment
consist
administ
oxygen
maintain
oxygen
satur
children
inhal
agonist
fig
although
rapidact
inhal
agonist
gener
administ
nebu
lizat
equival
bronchodil
rapid
onset
fewer
side
effect
less
time
emerg
depart
achiev
mdi
spacer
airflow
obstruct
respond
adequ
bronchodil
deliveri
mdi
continu
nebul
therapi
shown
effect
compar
similar
therapi
administ
intermitt
administr
subcutan
intramuscular
epinephrin
reserv
emerg
situat
aerosol
deliveri
agonist
possibl
acut
airflow
obstruct
part
gener
anaphylact
reaction
use
addit
bronchodil
therapi
eg
ipratropium
bromid
theophyllin
set
acut
asthmat
exacerb
also
evalu
combin
agonist
ipratropium
bromid
anticholinerg
agent
may
produc
better
bronchodil
either
drug
alon
associ
lower
hospit
rate
adult
pediatr
patient
efficaci
intraven
aminophyllin
acut
sever
asthma
evalu
accumul
evid
major
patient
support
routin
use
set
high
riskbenefit
ratio
treatment
glucocorticosteroid
inhal
oral
andor
parenter
mainstay
treatment
asthma
exacerb
varieti
approach
evalu
treatment
exacerb
rang
mild
sever
overal
result
indic
import
treat
patient
individu
base
prior
pattern
therapeut
respons
andor
natur
sever
current
clinic
present
address
home
treatment
mild
exacerb
increas
dose
baselin
ic
intermitt
intervent
high
dose
ic
may
efficaci
avert
progress
symptom
particularli
children
patient
emerg
depart
treatment
children
adult
high
dose
ic
current
receiv
corticosteroid
therapi
may
reduc
risk
subsequ
hospit
moder
sever
exacerb
system
corticosteroid
usual
requir
enhanc
speed
resolut
symptom
significantli
improv
varieti
outcom
measur
consid
integr
treatment
episod
especi
initi
rapidact
inhal
agonist
dose
fail
achiev
last
improv
exacerb
develop
even
though
patient
take
oral
corticosteroid
previou
exacerb
requir
oral
corticosteroid
system
corticosteroid
requir
least
hour
produc
clinic
improv
metaanalysi
suggest
dose
corticosteroid
equival
mg
methylprednisolon
mg
hydrocortison
per
day
adequ
hospit
patient
even
mg
methylprednisolon
mg
hydrocortison
probabl
adequ
convinc
data
proper
durat
oral
prednison
treatment
although
cours
adult
cours
children
usual
consid
appropri
current
evid
suggest
benefit
taper
dose
oral
prednison
either
short
term
sever
week
formul
strategi
treatment
chronic
asthma
goal
therapi
need
develop
includ
defin
asthma
control
follow
criteria
may
achiev
everi
patient
provid
reason
criteria
treatment
minim
none
chronic
symptom
includ
nocturn
symptom
reduc
frequenc
exacerb
includ
need
emerg
room
visit
hospit
minim
need
acut
rescu
therapi
inhal
agonist
establish
normal
lifestyl
limit
activ
includ
exercis
normal
pulmonari
function
minim
advers
effect
medic
although
select
pharmacolog
treatment
determin
depend
upon
mani
factor
gener
base
sever
asthma
asthma
variabl
chronic
diseas
syndrom
specif
treatment
need
adjust
acut
exacerb
chronic
maintain
adequ
symptom
control
minim
side
effect
cost
prolong
period
time
accomplish
goal
stepwis
approach
adapt
treatment
fig
http
wwwnhlbinihgovguidelinesasthma
asthsummhtm
basi
stepwis
approach
increas
number
frequenc
dose
medic
increas
asthma
sever
patient
diseas
put
remiss
usual
initi
treatment
given
high
level
appropri
asthma
sever
control
achiev
care
stepdown
therapi
consid
maintain
diseas
remiss
fewest
number
medic
least
number
side
effect
variou
treatment
asthma
sever
divid
intermitt
persist
divid
mild
moder
sever
fig
placement
patient
variou
step
base
featur
asthma
time
initi
evalu
patient
yet
receiv
medic
asthma
base
asthma
featur
andor
medic
requir
maintain
maximum
diseas
control
classif
intermitt
asthma
indic
level
sever
sinc
patient
categori
may
intermitt
symptom
symptom
develop
may
abrupt
sever
natur
asthma
complex
genet
disord
character
airway
inflamm
revers
airflow
obstruct
distinguish
multipl
phenotyp
may
differ
basi
age
onset
trigger
factor
pattern
sever
acut
exacerb
chronic
basi
reflect
variabl
revers
loss
lung
function
result
clinic
heterogen
treatment
approach
need
individu
modifi
obtain
maintain
adequ
symptom
diseas
control
time
although
current
therapi
target
develop
secondari
tertiari
prevent
strategi
ongo
research
evalu
prospect
primari
prevent
well
